Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer
-
Published:2019-03
Issue:3
Volume:39
Page:1317-1328
-
ISSN:0250-7005
-
Container-title:Anticancer Research
-
language:en
-
Short-container-title:Anticancer Res
Author:
ORTEGA-GRANADOS ANA LAURA,ARTAL-CORTES ÁNGEL,AGUIAR-BUJANDA DAVID,ORAMAS JUANA,FÍRVIDA JOSÉ LUIS,DE CASTRO JAVIER,FUENTES JUANA CAMPILLO,GORDO ROCÍO,GALÁN RAQUEL,TRIGO JOSÉ,
Publisher
Anticancer Research USA Inc.
Subject
Cancer Research,Oncology,General Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Erlotinib;Reactions Weekly;2019-05